Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Assertio Therapeutics Inc. (ASRT)

1.34   -0.01 (-0.74%) 02-14 16:00
Open: 1.36 Pre. Close: 1.35
High: 1.41 Low: 1.32
Volume: 989,348 Market Cap: 108M
Assertio Therapeutics, Inc., a specialty pharmaceutical company, provides medicines in neurology, orphan, and specialty areas in the United States. The company offers Gralise (gabapentin), a once daily product for the management of postherpetic neuralgia; CAMBIA (diclofenac potassium for oral solution), a non-steroidal anti-inflammatory drug for the acute treatment of migraine attacks; and Zipsor (diclofenac potassium liquid filled capsules), a non-steroidal anti-inflammatory drug for treating mild to moderate acute pain. It also provides NUCYNTA ER (tapentadol extended release tablet), a product for the management of pain severe enough to require daily, around-the-clock, and long term opioid treatment, including neuropathic pain related to diabetic peripheral neuropathy in adults; and NUCYNTA IR (tapentadol), a product for the management of moderate to severe acute pain in adults. In addition, the company offers long-acting cosyntropin, an alcohol-free formulation of synthet

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.413 - 1.421 1.421 - 1.429
Low: 1.298 - 1.307 1.307 - 1.316
Close: 1.324 - 1.339 1.339 - 1.355

Technical analysis

as of: 2020-02-14 4:26:41 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 1.68     One year: 2.00
Support: Support1: 1.01    Support2: 0.84
Resistance: Resistance1: 1.44    Resistance2: 1.71
Pivot: 1.20
Moving Average: MA(5): 1.35     MA(20): 1.20
MA(100): 1.06     MA(250): 2.44
MACD: MACD(12,26): 0.06     Signal(9): 0.04
Stochastic oscillator: %K(14,3): 48.10     %D(3): 48.57
RSI: RSI(14): 59.52
52-week: High: 5.76  Low: 0.68  Change(%): -70.1
Average Vol(K): 3-Month: 294339  10-Days: 434594

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
ASRT has closed below upper band by 26.9%. Bollinger Bands are 50.9% wider than normal. The large width of the bands suggest high volatility as compared to ASRT's normal range. The bands have been in this wide range for 2 bars. This is a sign that the current trend might continue.

Headline News

Is ASSERTIO THERAPEUTICS, INC (ASRT) Outperforming Other Medical Stocks This Year?
Is (ASRT) Outperforming Other Medical Stocks This Year?

Assertio Therapeutics Announces Closing of Gralise® Sale to Alvogen and Expects Full-Year 2019 Neurology Franchise Net Sales Above Upper End of Prior Guidance | MarketScreener
LAKE FOREST, Ill., Jan. 13, 2020 -- Assertio Therapeutics, Inc. , today announced the closing of its previously disclosed agreement with Alvogen, a global privately held pharmaceutical… | January 13, 2020

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NasdaqGS
Sector:  Healthcare
Industry:  Drug Manufacturers - Specialty Generic
Shares Out. (M) 80.68
Shares Float (M) 69.96
% Held by Insiders 1.29
% Held by Institutions 91.14
Shares Short (K) 12850
Shares Short P. Month (K)

Stock Financials

EPS -0.970
Book Value (p.s.) 3.080
PEG Ratio 0.05
Profit Margin -22.88
Operating Margin -6.59
Return on Assets (ttm)
Return on Equity (ttm) -19.9
Qtrly Rev. Growth -28.8
Gross Profit (p.s.) 3.635
Sales Per Share
EBITDA (p.s.) 1.068
Qtrly Earnings Growth -93.10
Operating Cash Flow (M) 98.38
Levered Free Cash Flow (M) 106.86

Stock Valuations

P/E -1.38
P/E Growth Ratio -0.01
P/BV 0.44
P/S 0.41
P/CF 1.10

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.